ClinicalTrials.gov
public full text
Public Domain
Dasatinib in Polycythemia Vera
The purpose for conducting this research study is to determine the feasibility of using dasatinib as a treatment for polycythemia vera and to determine the optimum treatment regimen.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder#884250
- A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer#879817
- Dasatinib for the Treatment of Moderate and Severe COVID-19#847599
- Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors#245375
- Treatment of Adult Ph+ LAL With BMS-354825#843019
Record · ID 848040
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive